U.S. markets closed
  • S&P 500

    3,465.39
    +11.90 (+0.34%)
     
  • Dow 30

    28,335.57
    -28.13 (-0.10%)
     
  • Nasdaq

    11,548.28
    +42.28 (+0.37%)
     
  • Russell 2000

    1,640.50
    +10.25 (+0.63%)
     
  • Crude Oil

    39.78
    -0.07 (-0.18%)
     
  • Gold

    1,903.40
    -1.80 (-0.09%)
     
  • Silver

    24.70
    +0.03 (+0.10%)
     
  • EUR/USD

    1.1858
    +0.0032 (+0.27%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • GBP/USD

    1.3064
    -0.0016 (-0.12%)
     
  • USD/JPY

    104.7300
    -0.1100 (-0.10%)
     
  • BTC-USD

    13,024.00
    +6.47 (+0.05%)
     
  • CMC Crypto 200

    260.05
    -1.40 (-0.54%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,516.59
    +42.29 (+0.18%)
     

The Zacks Analyst Blog Highlights: Nu Skin Enterprises, Clorox, B&G Foods, Nomad Foods and Kellogg

Zacks Equity Research
·6 mins read

For Immediate Release

Chicago, IL – July 17, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Nu Skin Enterprises, Inc. NUS, The Clorox Co. CLX, B&G Foods, Inc. BGS, Nomad Foods Ltd. NOMD and Kellogg Co. K.

Here are highlights from Thursday’s Analyst Blog:

5 Consumer Staples Stocks with Real Earnings Beat Potential

Even amid the pandemic-led jeopardized economy, the Consumer Staples space has been a relatively safe spot. As the sector houses companies offering essentials like packaged foods and beverages, cleaning products, and household and personal care products, among others, it has been in a good position as demand for such products has been high amid the pandemic-induced stockpiling and increased at-home consumption.

We note that the performance of several consumer staple players (especially packaged food and cleaning material companies) has been benefiting from burgeoning demand owing to the coronavirus-led stock hoarding and elevated stay-at-home trends. Further, the gradual reopening of stores, salons and other businesses along with the lifting of certain curbs since May has brought back operations of a number of companies on track, which were otherwise hurt for a while.

We expect these upsides to be reflected in the performance of many players from the Consumer Staples space this earnings season. Apart from this, companies from this space have been benefiting from contributions from buyouts, product innovation and other brand-building efforts. Further, their stringent saving and restructuring efforts have been helping them tackle cost inflation as well as expenditures related to managing operations amid the COVID-19 crisis.

All said, we have brought focus on some consumer staple stocks, which carry a favorable Zacks Rank and have the potential to beat earnings estimates this reporting cycle. Also, most of these companies have delivered returns of more than 8% in the past three months.

Here’s the Right Way to Pick Them

We used the Zacks Stock Screener to identify five well-ranked consumer staple stocks, which are poised to beat the Zacks Consensus Estimate this earnings season. Our research shows that for stocks with the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), the chances of a positive earnings surprise are as high as 70%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

5 Potential Winners

Nu Skin Enterprises, Inc. is a provider of premium cosmetics, beauty and personal care products. The stock has a Zacks Rank #1 and an Earnings ESP of +13.74%. The company has delivered an earnings surprise of 13.5%, on average, in the trailing three quarters. Carrying a VGM Score of B, shares of Nu Skin have rallied considerably over the past three months. The Zacks Consensus Estimate for earnings in the to-be-reported quarter is pegged at 59 cents per share. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Clorox Co.has rallied 14.8% in the past three months. The stock, which has a Zacks Rank #2 and an Earnings ESP of +0.67%, is worth betting on. The Zacks Consensus Estimate for earnings in the to-be-reported quarter is pegged at $1.99 per share, suggesting growth of 5.9% from the prior-year quarter’s reported figure. This cleaning and household products company has a trailing four-quarter earnings surprise of 6.6%, on average.

Another worthwhile option is B&G Foods, Inc., with a Zacks Rank #2 and an Earnings ESP of +1.56%. The Zacks Consensus Estimate for first-quarter 2020 earnings is pegged at 64 cents per share, suggesting growth of 68.4% from the prior-year period’s reported figure. The company, which produces frozen foods and household products, delivered an earnings surprise of 5.4%, on average, in the trailing four quarters and has a VGM Score of A. Shares of the company have gained 28.3% in the past three months.

Nomad Foods Ltd.,which has gained 9.6% in the past three months, also deserves a mention. The stock has a Zacks Rank #2 and an Earnings ESP of +6.25%. The Zacks Consensus Estimate for first-quarter 2020 earnings is pegged at 32 cents, indicating growth of 6.7% from the year-ago quarter’s reported figure. This frozen food provider has a trailing four-quarter earnings surprise of 10.7%, on average.

Investors can even count on Kellogg Co., a ready-to-eat convenience food manufacturer, with a Zacks Rank #2 and an Earnings ESP of +1.08%. The company has a trailing four-quarter earnings surprise of 8.3%, on average, and returned 6.2% in the past three months. The consensus mark for second-quarter earnings is pegged at 93 cents. Kellogg flaunts a VGM Score of A.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                   

https://www.zacks.com                                                 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Kellogg Company (K) : Free Stock Analysis Report
 
The Clorox Company (CLX) : Free Stock Analysis Report
 
Nu Skin Enterprises, Inc. (NUS) : Free Stock Analysis Report
 
BG Foods, Inc. (BGS) : Free Stock Analysis Report
 
Nomad Foods Limited (NOMD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.